THE MCMANUS GROUP for NOVARTIS
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Advocacy regarding access to 340B reimbursement.
Foreign entity interest: Novartis AG, Fabrikstrasse 2, 4056 Basel, Switzerland
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MCMANUS | — |
| BARRETT THORNHILL | — |
Medicare/Medicaid MMM
Pharmaceutical coverage and access in Parts A, B, C, and D.
Foreign entity interest: Novartis AG, Fabrikstrasse 2, 4056 Basel, Switzerland
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MCMANUS | — |
| BARRETT THORNHILL | — |
Copyright/Patent/Trademark CPT
Legislation amending the Patent Act, including reforms to patent eligible subject matter. S. 1416, the Affordable Prescriptions for Patients Act of 2019.
Foreign entity interest: Novartis AG, Fabrikstrasse 2, 4056 Basel, Switzerland
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHRISTINA HOCHUL | — |
| JOHN MCMANUS | — |
| BARRETT THORNHILL | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.